Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results

Rhea-AI Summary

Artivion (NYSE:AORT) will release Q1 2026 financial results on May 7, 2026 after market close, followed by a teleconference and live webcast at 4:30 p.m. ET.

Pat Mackin, Chairman, President and CEO, will host the call with a Q&A. Replay and webcast will be available via the Investors section of the Artivion website and by telephone replay.

News Market Reaction – AORT

+1.61%

+1.61% Session close to close

In the Apr 24 session, AORT gained 1.61%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets the timeline for Artivion’s first quarter 2026 results, with a release on May...

Analysis

This announcement sets the timeline for Artivion’s first quarter 2026 results, with a release on May 7, 2026 after the close and a 4:30 p.m. ET teleconference. Historically, similar conferences/earnings notices have led to modest one-day moves averaging about 1.02%. Investors may focus on how upcoming results relate to prior strong 2025 performance and recent FDA and clinical milestones, while tracking any additional disclosures in the forthcoming earnings press release and webcast materials.

Key Figures

Results date: May 7, 2026 Quarter: First quarter 2026 Call time: 4:30 p.m. ET +5 more

8 metrics

Results date May 7, 2026 First quarter 2026 financial results release after market close

Quarter First quarter 2026 Period to be discussed on upcoming earnings call

Call time 4:30 p.m. ET Start time for teleconference and webcast on results day

Live dial-in 201-689-8261 Number to access the live first-quarter 2026 teleconference

Replay toll-free 877-660-6853 Toll-free phone number for the teleconference replay

Replay number 201-612-7415 Additional phone line to access the replay

Conference ID 13759187 Conference number required to access the call replay

Pre-news price move 1.29% AORT 24h change prior to this scheduling announcement

Previous Conferences,earnings Reports

5 past events · Latest: Jan 29 (Neutral)

Same Type Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jan 29	Earnings call scheduling	Neutral	+0.9%	Set Q4 2025 results release date and teleconference details.
Oct 23	Earnings call scheduling	Neutral	+0.0%	Announced Q3 2025 results date and investor call information.
Jul 24	Earnings call scheduling	Neutral	+1.1%	Outlined Q2 2025 release timing and webcast participation details.
Apr 21	Earnings call scheduling	Neutral	+3.3%	Provided Q1 2025 results date and access info for call and webcast.
Feb 10	Earnings call scheduling	Neutral	-0.2%	Scheduled Q4 and full-year 2024 results release and investor call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Scheduling earnings release and call details has historically led to small, generally positive one-day moves around 0–3% for AORT.

Recent Company History

Over the past year, Artivion has repeatedly issued notices setting dates and call details for quarterly and full‑year results, typically with CEO Pat Mackin hosting a 4:30 p.m. ET webcast. Prior events on Feb 24, 2025, Apr 21, 2025, Jul 24, 2025, Oct 23, 2025, and Jan 29, 2026 produced modest price reactions between about -0.2% and 3.28%. Today’s first‑quarter 2026 scheduling fits this established pattern of routine pre‑earnings communications.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ATLANTA, April 23, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2026 financial results will be released on Thursday, May 7, 2026, after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question-and-answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of Artivion.

To listen to the live teleconference, please dial 201-689-8261 a few minutes prior to 4:30 p.m. ET. The teleconference replay will be available approximately one hour following the completion of the event and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13759187.

The live webcast and replay can be accessed on the Investors section of the Artivion website at www.artivion.com and by selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investors section of the Artivion website.

About Artivion, Inc.

Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Contacts:

Artivion	Gilmartin Group LLC
Lance A. Berry	Brian Johnston
Executive Vice President, Chief Operating Officer & Chief Financial Officer	Phone: 332-895-3222
Phone: 770-419-3355	investors@artivion.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-announces-release-date-and-teleconference-call-details-for-first-quarter-2026-financial-results-302752177.html

SOURCE Artivion, Inc.

FAQ

When will Artivion (AORT) release its Q1 2026 earnings and hold the earnings call?

Artivion will release Q1 2026 results on May 7, 2026 after market close, with a teleconference and webcast at 4:30 p.m. ET. According to Artivion, the event will include a Q&A hosted by CEO Pat Mackin.

How can investors listen to the Artivion (AORT) Q1 2026 teleconference live?

Investors can join live by dialing 201-689-8261 a few minutes before 4:30 p.m. ET. According to Artivion, the teleconference will also be streamed live on the Investors section of the company website.

Will Artivion (AORT) provide a replay of the Q1 2026 earnings call and where is it available?

A teleconference replay will be available about one hour after the event via toll-free 877-660-6853 or 201-612-7415 using conference number 13759187. According to Artivion, a webcast replay will be on the Investors website.

Who will host the Artivion (AORT) Q1 2026 earnings call and will there be a Q&A session?

Pat Mackin, Chairman, President and CEO, will host the call and lead a question-and-answer session following the presentation. According to Artivion, management will address investor questions on the teleconference.

Where can I find the Artivion (AORT) Q1 2026 earnings press release and supporting financial details?

The earnings press release and quarter/full-year financial information will be posted in the Investors section of Artivion's website under Webcasts & Presentations. According to Artivion, the release will include financial and statistical information for the completed quarter and full year.